Radius Health Inc

Radius Health Inc is a biopharmaceutical company that specializes in developing and commercializing innovative therapeutics for patients suffering from osteoporosis and other serious endocrine-mediated diseases. Their flagship product, TYMLOS, is a synthetic peptide analog of the human parathyroid hormone that is used to treat postmenopausal women with osteoporosis at high risk for fracture. The company is dedicated to advancing the science of endocrine-mediated diseases and developing new treatments that address unmet medical needs, with a team of experienced professionals committed to delivering high-quality products and services that meet the needs of patients, healthcare providers, and other stakeholders. With a robust pipeline of potential new therapies, Radius Health is well-positioned to continue its growth and success in the biopharmaceutical industry.